<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" coord="1,136.70,105.07,342.84,15.12">Overview of the TREC 2022 Clinical Trials Track</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName coords="1,276.46,137.56,67.20,10.48"><forename type="first">Kirk</forename><surname>Roberts</surname></persName>
						</author>
						<author>
							<persName coords="1,250.61,178.95,118.90,10.48"><forename type="first">Dina</forename><surname>Demner-Fushman</surname></persName>
						</author>
						<author>
							<persName coords="1,263.13,220.34,93.86,10.48"><forename type="first">Ellen</forename><forename type="middle">M</forename><surname>Voorhees</surname></persName>
						</author>
						<author>
							<persName coords="1,223.22,261.73,74.57,10.48"><forename type="first">Steven</forename><surname>Bedrick</surname></persName>
						</author>
						<author>
							<persName coords="1,306.95,261.73,89.97,10.48"><forename type="first">William</forename><forename type="middle">R</forename><surname>Hersh</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">School of Biomedical Informatics</orgName>
								<orgName type="institution">The University of Texas Health Science Center</orgName>
								<address>
									<settlement>Houston</settlement>
									<region>TX</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="institution">Lister Hill National Center for Biomedical Communications</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="institution">U.S. National Library of Medicine</orgName>
								<address>
									<settlement>Bethesda</settlement>
									<region>MD</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="laboratory">Information Technology Laboratory</orgName>
								<orgName type="institution">National Institute of Standards and Technology</orgName>
								<address>
									<settlement>Gaithersburg</settlement>
									<region>MD</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="department">Department of Medical Informatics &amp; Clinical Epidemiology</orgName>
								<orgName type="institution">Oregon Health and Science University</orgName>
								<address>
									<settlement>Portland</settlement>
									<region>OR</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" coord="1,136.70,105.07,342.84,15.12">Overview of the TREC 2022 Clinical Trials Track</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">F369B17821D9AACB63029F9BCD204604</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.0" ident="GROBID" when="2024-08-05T15:11+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Clinical trials are the primary means for new medical treatments-such as drugs, surgical procedures, and behavior interventions-to demonstrate their effectiveness in an evidence-based manner. However, clinical trials have high costs, can take years to complete, and oftentimes fail to identify a sufficient number of patients to establish clinical significance. Automated methods for improving the patient recruitment process can aid in all three areas: reducing manual and expensive chart review, more quickly identifying eligible patients, and expanding the pool of candidate patients that may be eligible.</p><p>The primary means of automating clinical trial recruitment is through the use of electronic health record (EHR) data. EHRs are responsible for documenting routine medical care, as well as being the legal and billing record. However, the re-use of EHR data for research is well-established <ref type="bibr" coords="1,418.21,448.11,57.05,8.74" target="#b7">(Hersh, 2007)</ref>, commonly for observational studies but also as the source data for informatics-driven models, including machine learning (ML) and information retrieval (IR). This was the inspiration behind the TREC Medical Records track (2011-2012) (Voorhees and Tong, 2011; Voorhees and Hersh, 2012), which used short cohort descriptions as queries (e.g., "Patients treated for vascular claudication surgically") and used EHR visit records as the document collection. Unfortunately, this track was discontinued due to the the lack of an EHR dataset of sufficient size to merit a proper IR evaluation. The TREC Clinical Trials track, instead, flips the trial-topatients paradigm to a patient-to-trials paradigm. This has enabled the building of a large test collection for clinical trial search. In this paradigm, the topic is a (synthetic) patient description and the document collection is a large set of clinical trial descriptions (which are, notably, publicly and freely available).</p><p>There are several challenges involved with task, however. The first set of challenges revolve around using clinical trial descriptions as the document collection. Clinical trial descriptions are often very long (see link to trial in Table <ref type="table" coords="1,169.93,591.57,3.87,8.74">2</ref>). The core part of the description with regards to trial matching is the eligibility criteria, a (often long) list of inclusion criteria (the patient must meet all these requirements) and exclusion criteria (if the patient meets any of these criteria, they are ineligible and would be excluded from the trial). These criteria not only use complex medical terminology, but they are often written in a way that does not correspond directly to how patient cases are described in the EHR, making direct term mapping problematic.</p><p>The second set of challenges revolves around the patient cases. In addition to the linguistic issues of how identical clinical concepts in EHR text versus trial descriptions, patient cases contain significant amounts of extraneous information with respect to the clinical trial. That is, not all of the information in a patient case need be covered in the trial. Rather, a sufficient amount of information must be present to suggest the patient may be eligible, while also not containing information showing the patient to be excluded. This</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>means that many of the conditions in the patient description are irrelevant for a single clinical trial, whereas matching to a different clinical trial may involve a different subset of conditions in the patient case.</p><p>As in 2021 <ref type="bibr" coords="2,137.44,92.09,93.45,8.74" target="#b10">Roberts et al. (2021b)</ref>, to ensure this task focuses on information retrieval and not supervised information extraction, we present a lengthy (5-10 sentence) patient case description as the topic that simulates an admission statement in an EHR. The evaluation is further be broken down into Eligible, Excludes, and Not Relevant to allow retrieval methods to distinguish between patients that do not have sufficient information to qualify for the trial (Not Relevant) and those that are explicitly Excluded. This latter category can be difficult for retrieval systems without strong semantic understanding.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p>There is a long-established history of biomedical IR tracks within TREC. This includes the Genomics track <ref type="bibr" coords="2,73.99,218.59,23.15,8.74">(2003)</ref><ref type="bibr" coords="2,97.14,218.59,4.63,8.74">(2004)</ref><ref type="bibr" coords="2,97.14,218.59,4.63,8.74">(2005)</ref><ref type="bibr" coords="2,97.14,218.59,4.63,8.74">(2006)</ref><ref type="bibr" coords="2,101.77,218.59,23.15,8.74">(2007)</ref>  <ref type="bibr" coords="2,127.87,218.59,132.56,8.74" target="#b3">(Hersh and Bhupatiraju, 2003;</ref><ref type="bibr" coords="2,263.39,218.59,73.88,8.74" target="#b4">Hersh et al., 2004</ref><ref type="bibr" coords="2,344.77,218.59,18.15,8.74" target="#b5">Hersh et al., , 2005</ref><ref type="bibr" coords="2,370.42,218.59,22.14,8.74" target="#b6">Hersh et al., , 2006))</ref>, the Medical Records (2011-2012) <ref type="bibr" coords="2,73.99,230.55,120.21,8.74" target="#b18">(Voorhees and Tong, 2011;</ref><ref type="bibr" coords="2,198.82,230.55,119.19,8.74" target="#b17">Voorhees and Hersh, 2012)</ref>, the Clinical Decision Support track (2015-2016) <ref type="bibr" coords="2,73.99,242.50,94.71,8.74" target="#b16">(Simpson et al., 2014;</ref><ref type="bibr" coords="2,172.03,242.50,83.98,8.74" target="#b15">Roberts et al., 2015</ref><ref type="bibr" coords="2,263.87,242.50,22.14,8.74" target="#b9">Roberts et al., , 2016))</ref>, the Precision Medicine track (2018-2020) <ref type="bibr" coords="2,475.87,242.50,66.37,8.74;2,73.99,254.46,18.15,8.74" target="#b14">(Roberts et al., 2017</ref><ref type="bibr" coords="2,99.80,254.46,18.15,8.74" target="#b12">(Roberts et al., , 2018</ref><ref type="bibr" coords="2,125.62,254.46,18.15,8.74" target="#b13">(Roberts et al., , 2019</ref><ref type="bibr" coords="2,151.44,254.46,22.14,8.74" target="#b11">(Roberts et al., , 2020))</ref>, the Health Misinformation track (2019-2021) <ref type="bibr" coords="2,379.25,254.46,103.79,8.74" target="#b0">(Abualsaud et al., 2019;</ref><ref type="bibr" coords="2,486.15,254.46,56.09,8.74;2,73.99,266.41,18.15,8.74" target="#b2">Clarke et al., 2020</ref><ref type="bibr" coords="2,99.44,266.41,22.14,8.74" target="#b1">Clarke et al., , 2021))</ref>, and the TREC-COVID track <ref type="bibr" coords="2,257.10,266.41,95.02,8.74">(Roberts et al., 2021a)</ref>. Of all these tracks, the Precision Medicine track is the most similar to the Clinical Trials track. Indeed, one of the tasks for the TREC Precision Medicine track was to retrieve clinical trials for synthetic patient topics. The TREC Clinical Trials track, then, has expanded this notion of clinical trial search beyond the precision medicine paradigm to all human clinical trials.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Topics</head><p>Within the context of the TREC Clinical Trials track for 2021 and 2022, a topic is a brief patient case description, such as what may be included as part of an admission note. Four of the 2022 topics are shown in Table <ref type="table" coords="2,112.24,392.91,3.87,8.74" target="#tab_0">1</ref>. Most topics are prose paragraphs, resembling a traditional medical case description, while others have additional information in the form of a list, oftentimes lab values (which are frequently used for clinical trial eligibility). All topics tend to use language and abbreviations found in clinical notes. All the topics were derived with a specific disease in mind (e.g., the first topic from Table <ref type="table" coords="2,390.32,428.78,4.98,8.74" target="#tab_0">1</ref> is an ectopic pregnancy patient), but this disease was not provided to participants or judges. Ultimately, a patient could be eligible for trials outside the intended disease-the disease was simply used to ensure a broad distribution of topics.</p><p>The 2022 track had 50 topics, which was a slight decrease from 2021 in order to ensure deeper pools could be made for evaluation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data</head><p>The 2022 track used the same snapshot of ClinicalTrials.gov that was used for the 2021 Clinical Trials track. Briefly, the collection is a April 27, 2021 snapshot of all the clinical trials available on ClinicalTrials.gov. U.S. policy dictates that all clinical trials conducted in the United States post their trial information to this website, which is maintained by the U.S. National Library of Medicine. The collection used for the task was hosted on the trec-cds.org website that maintains the topics and data for many biomedical TREC tracks. The data is available as XML, with this specific snapshot containing 375,581 clinical trial descriptions. Each clinical trial is assigned a National Clinical Trial (NCT) designation number (e.g., NCT00392756), which is used as the document ID for the track. These are the same IDs reported in the final publications describing the clinical trial results (a common clinical journal requirement).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Assessment</head><p>Assessment used the same interface as in 2021 (see Figure <ref type="figure" coords="2,339.16,681.77,3.87,8.74" target="#fig_0">1</ref>), which was modified from prior biomedical TREC tracks. Also as in 2021, assessors judged results with a 3-point scale:</p><p>Topic 2 A 32-year-old woman comes to the hospital with vaginal spotting. Her last menstrual period was 10 weeks ago. She has regular menses lasting for 6 days and repeating every 29 days. Medical history is significant for appendectomy and several complicated UTIs. She has multiple male partners, and she is inconsistent with using barrier contraceptives. Vital signs are normal. Serum β-hCG level is 1800 mIU/mL, and a repeat level after 2 days shows an abnormal rise to 2100 mIU/mL. Pelvic ultrasound reveals a thin endometrium with no gestational sac in the uterus. Topic 6</p><p>A 61-year-old man comes to the clinic due to nonproductive cough and progressive dyspnea. The patient's medical conditions include hypertension, hypercholesteremia and peptic ulcer disease. He smokes 2 packs of cigarettes daily for the past 30 years. On examination, there are decreased breath sounds and percussive dullness at the base of the left lung. Other vital signs are normal. Abdomen is soft without tenderness. CT scan shows a left-sided pleural effusion and nodular thickening of the pleura. The plural fluid was bloody on thoracentesis. Biopsy shows proliferation of epithelioid-type cells with very long microvilli.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Topic 19</head><p>A 7-year-old girl is brought to the emergency department by her parents for generalized rash. The mother reports that she was playing outside wearing a skirt and felt a sharp pain in her arm while seating on a mat, plying with her doll. Her mother suspects that something had stung her. The patient's blood pressure is 75/55 mm Hg and her heart rate is 122/min. Physical examination shows erythematous, raised plaques over the trunk, extremities, and face. Lung auscultation reveals bilateral expiratory wheezes.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Topic</head><p>A 15-year-old boy with mild intellectual disability is brought to the office by his parents for a routine physical examination. The boy is going to a school for students with learning disabilities. The patient was adopted, and his immunizations are up to date. Review of the patient's medical records is notable for cytogenetic studies that showed a small gap near the tip of the long arm of the X chromosome, which is consistent with fragile X syndrome, an X-linked disorder. The defect is an unstable expansion of trinucleotide repeats (CGG) in the fragile X mental retardation 1 (FMR1) gene, located on the long arm of the X chromosome. He is not using any medications and vital signs are within normal levels. His blood chemistry analysis as bellow:  1. Not Relevant. The patient is not relevant for the trial in any way. 2. Excluded. The patient has the condition that the trial is targeting, but the exclusion criteria make the patient ineligible. 3. Eligible. The patient is eligible to enroll in the trial.</p><p>Prior to the assessment process, the assessors were asked to spend 20-30 minutes to get any necessary background on the topic. This includes familiarizing themselves with the patient's case, any mentioned diseases, as well as the types of trials available for these diseases on ClinicalTrials.gov to get a sense for both the site itself and the ways in which the specific diseases were described in the clinical trial eligibility criteria.</p><p>Table <ref type="table" coords="4,116.47,581.08,4.98,8.74" target="#tab_1">2</ref> gives a sense for what clinical trial eligibility criteria (both inclusion and exclusion) look like in the trial descriptions. Two important conditions were not considered reasons for ineligibility:</p><p>• Recruitment Status. Clinical trials only allow recruitment during a specified window, ending either once the trial meets its recruitment goal, at a specified time point, or when the trial ia canceled. This also includes excluding recruitment prior to the start of the trial, as well as after recruitment has ended (which is still prior to study completion). Since this is not really a textual/semantic aspect relevant to information retrieval, we ignored the recruitment status. This increases the number of relevant patient/trial matches.</p><p>• Location. Many trials only enroll patients at certain locations. We ignored this as well, which also increases the number of relevant trials. The patients should also have had pain in the affected knee on most days over the last month. 6. Patients who are willing to discontinue all non-steroidal anti-inflammatory drugs (NSAIDs) or other analgesic medication taken for any condition, including their knee pain, 7. Patients who are on stable dose of opioids for at least 1 month before screening can continue to take their opioid at this stable dose throughout the study. 8. Patients must also be willing to abstain from any intra-articular or peri-articular injections to the knee or surgery during the treatment period 9. Patients who, if they are currently taking aspirin (325 mg/day or less; as anti-coagulants), are willing to remain on a stable dose one month prior to screening and throughout the study Exclusion Criteria:</p><p>1. Subjects with known hypersensitivity to any biological or investigational drugs.</p><p>2. Patients with contraindications to knee injections 3. Patients with joint effusion 4. Patients should not have rheumatoid arthritis or any connective tissue like disease 5. Secondary osteoarthritis with history and/or any evidence of the following diseases: septic arthritis, inflammatory joint disease, gout, Paget's disease of the bone, articular fracture, major dysplasias or congenital abnormality, ochronosis, acromegaly, hemochromatosis, Wilson's disease, primary osteochondromatosis, juvenile chronic arthritis with continued activity in adulthood, heritable disorders (e.g. hypermobility). Patients with secondary osteoarthritis following menisectomy or injuries of a collateral or cruciate ligament are not excluded. 6. Presence or history of underlying metabolic, endocrine, hematologic, pulmonary, cardiac, blood, renal, hepatic, infectious, psychiatric or gastrointestinal conditions 7. Evidence of tuberculosis (TB) 8. One of the risk factors for TB such as:</p><p>(a) Substance abuse (e.g. injection or non-injection) (b) Health-care workers with unprotected exposure to patients who are at high risk of TB (c) Patients with TB disease before the identification and correct airborne precautions of the patient (d) close contact (i.e. share the same air space in a household or other enclosed environment for a prolonged period (days or weeks, not minutes or hours)) with a person with active pulmonary TB disease. 9. Significant medical problems, including but not limited to the following: uncontrolled hypertension,congestive heart failure, uncontrolled diabetes type I and II 10. Subjects with evidence of hepatic or blood coagulation disorders (i.e. hemophilia, etc), anemia, idiopathic thrombocytopenic purpura, or gastrointestinal disorder: severe hepatic disease, history of alcohol and drug abuse; disease of gall bladder and pancreas; active peptic ulceration, gastrointestinal bleeding or history of severe gastro-esophageal reflux disease or severe hiatus hernia; inflammatory bowel disease. 11. Use of any therapeutic protein drug (e.g. anti-tumor necrosis factor alpha (TNFα) antibody) 12. Presence of severe renal function impairment. History of renal trauma, glomerulonephritis, patients with one kidney, or renal failure requiring regular dialysis treatment. 13. Pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception and until the termination of gestation, confirmed by a positive pregnancy test (serum or urine). 14. Subjects with known contra-indications to naproxen (e.g. heart or circulation problems, history of ulcer disease etc.), analgesics, antipyretics, or NSAIDs. 15. Disease of the spine or other lower extremity joints which may interfere with the assessment of the target joint. 16. Surgery on the knee within the last year. Observational arthroscopy, arthroscopic surgery or lavage of the knee within the last 6 months. 17. Use of assistive devices other than a cane (walking stick) or knee brace. 18. Subjects who have experienced, any time in the past, asthma, acute rhinitis, nasal polyps, angioneurotic edema, urticaria or other allergic-type reaction after taking acetylsalicylic acid (ASA)/ aspirin or NSAIDs. 19. Any history of prior peptic ulcer disease or prior NSAID gastrointestinal complications for the past 5 years. 20. Other protocol defined inclusion/exclusion criteria may apply. URL: https://www.clinicaltrials.gov/ct2/show/NCT01160822 In other words, time and space are not considered when assessing eligibility, only the medical inclusion/exclusion criteria for the trial itself.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Evaluation</head><p>The 2022 Clinical Trials track evaluation followed standard TREC evaluation procedures for ad hoc retrieval tasks, as was the case for 2021. Participants submitted results in the trec eval format, with a maximum of five runs (automatic or manual) per task. Each run consisted of a ranked list of up to 1,000 clinical trial IDs (ClinicalTrials.gov Identifiers) per topic. The highest ranked trials for each topic were pooled and judged by physician graduate students at OHSU, indexers at the U.S. National Libary of Medicine, and other biomedical subject matter experts.</p><p>Due to the nature of the task, one can judge results according to both traditional relevance (Eligible and Excluded) as well as eligibility (Eligible). The focus of our evaluations for this track was on the latter, as this is more desirable from an application perspective. Explicitly, for NDCG, an Eligible trial was given a score of 2, an Excluded trial was given a score of 1, and a Not Relevant trial was given a score of 0. For all other metrics, Eligible is treated as relevant and Excluded is combined with Not Relevant.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p>A total of 41 runs were submitted by 11 teams. Of these, there were 6 manual runs and there were 35 automatic runs.</p><p>All 41 runs were pooled to depth 40. This resulted in a total of 35,394 runs for judging. The judged results include 3,949 Eligible trials (11%) and 3,047 Excluded trials (9%), with the remaining 28,481 trials judged Not Relevant. Table <ref type="table" coords="6,201.63,357.05,4.98,8.74" target="#tab_3">3</ref> shows the per-topic counts of relevant, partially relevant, and total judged trials.</p><p>Table <ref type="table" coords="6,116.70,380.96,4.98,8.74" target="#tab_4">4</ref> shows the participant results across the four primary metrics for the track (NDCG@10, P@10, RPrec, and MRR). Figures 2 shows the distribution of scores (only the best run per team) for each of the participants.</p><p>The per-topic perspective across all 41 runs is shown in Figures <ref type="figure" coords="6,375.67,416.82,4.98,8.74">3</ref> and<ref type="figure" coords="6,404.39,416.82,3.87,8.74">4</ref>. These figures demonstrate a wide range of scores, with many topics being "easy" for most participants, many topics being "hard" for most participants, and many other topics with a wide range of scores. When comparing these figures with Table <ref type="table" coords="6,101.33,452.69,3.87,8.74" target="#tab_3">3</ref>, there is a reasonable alignment between topics with few relevant results and those where the mean automatic runs were poor.   </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0" coords="4,210.45,446.58,195.32,8.74;4,97.41,65.03,421.41,366.44"><head>Figure 1 :</head><label>1</label><figDesc>Figure 1: Screenshot of assessment platform.</figDesc><graphic coords="4,97.41,65.03,421.41,366.44" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1" coords="5,90.77,143.66,73.12,6.12;5,90.77,151.61,432.00,6.14;5,90.77,159.58,304.52,6.14;5,90.77,167.57,63.25,6.12;5,104.47,175.54,290.89,6.12;5,104.47,183.51,205.61,6.12;5,104.47,191.48,120.76,6.12;5,104.47,199.45,240.67,6.12;5,104.47,207.42,160.90,6.12"><head></head><label></label><figDesc>To Determine the Safety, Tolerability, Pharmacokinetics and Effect on Pain of a Single Intra-articular Administration of Canakinumab in Patients With Osteoarthritis in the Knee Inclusion Criteria: 1. Written informed consent must be obtained before any assessment is performed. 2. Male and female patients aged 40 -80 years (inclusive). 3. Diagnosis of knee osteoarthritis 4. Radiographic evidence of tibiofemoral compartment osteoarthritis 5. Pain in the knee during the last 24 hours.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2" coords="7,177.81,638.32,28.12,8.74;7,221.43,638.32,216.99,8.74"><head>Figure 3 :Figure 4 :</head><label>34</label><figDesc>Figure Distribution of scores across topics for each team.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0" coords="3,90.45,528.85,365.19,130.28"><head>Table 1 :</head><label>1</label><figDesc>Example topics from the TREC 2022 Clinical Trials track.</figDesc><table coords="3,90.45,528.85,298.13,115.90"><row><cell>Blood Chemistry Value</cell><cell>Normal Range</cell><cell>Patient Value</cell></row><row><cell>Glucose</cell><cell>90-120 mg/dl</cell><cell>95 mg/dl</cell></row><row><cell cols="2">BUN (Blood Urea Nitrogen) 7-24 mg/dl</cell><cell>10 mg/dl</cell></row><row><cell>Creatinine</cell><cell>0.7-1.4 mg/dl</cell><cell>0.8 mg/dl</cell></row><row><cell>Calcium</cell><cell>8.5-10.5 mg/dl</cell><cell>9 mg/dl</cell></row><row><cell>Sodium</cell><cell>134-143 mEq/L</cell><cell>135 mEq/L</cell></row><row><cell>Potassium</cell><cell>3.5-4.5 mEq/L</cell><cell>3.7 mEq/L</cell></row><row><cell>Chloride</cell><cell>95-108 mEq/L</cell><cell>98 mEq/L</cell></row><row><cell>CO2</cell><cell>20-30 mEq/L</cell><cell>25 mEq/L</cell></row><row><cell>Blood pH</cell><cell>7.38-7.42</cell><cell>7. 39</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1" coords="5,179.96,633.85,256.32,8.74"><head>Table 2 :</head><label>2</label><figDesc>Example clinical trial inclusion/exclusion criteria.</figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3" coords="11,181.30,637.25,253.63,8.74"><head>Table 3 :</head><label>3</label><figDesc>Per-topic counts of relevant and partially-results.</figDesc><table coords="12,199.93,183.42,216.37,396.58"><row><cell>Run Name</cell><cell>Team</cell><cell>NDCG@10</cell></row><row><cell>frocchio monot5 e</cell><cell>h2oloo</cell><cell>0.6125</cell></row><row><cell>DoSSIER 5</cell><cell>DOSSIER</cell><cell>0.5565</cell></row><row><cell>ims RM3Filtered kw*</cell><cell>iiia-unipd</cell><cell>0.5051</cell></row><row><cell>monobert500</cell><cell>CSIROmed</cell><cell>0.4912</cell></row><row><cell>senttr</cell><cell>els dshs</cell><cell>0.4758</cell></row><row><cell>jbnu1</cell><cell>jbnu</cell><cell>0.4530</cell></row><row><cell>Run Name</cell><cell>Team</cell><cell>P@10</cell></row><row><cell>frocchio monot5 e</cell><cell>h2oloo</cell><cell>0.5080</cell></row><row><cell>DoSSIER 5</cell><cell cols="2">DOSSIER 0.4560</cell></row><row><cell>ims RM3Filtered kw*</cell><cell>iiia-unipd</cell><cell>0.3980</cell></row><row><cell>monobert500</cell><cell cols="2">CSIROmed 0.3620</cell></row><row><cell>senttr</cell><cell>els dshs</cell><cell>0.3540</cell></row><row><cell>jbnu2</cell><cell>jbnu</cell><cell>0.3220</cell></row><row><cell>Run Name</cell><cell>Team</cell><cell>RPrec</cell></row><row><cell>frocchio monot5 e</cell><cell>h2oloo</cell><cell>0.3297</cell></row><row><cell>DoSSIER 3</cell><cell cols="2">DOSSIER 0.2810</cell></row><row><cell>ims RM3Filtered kw*</cell><cell>iiia-unipd</cell><cell>0.2790</cell></row><row><cell>jbnu1</cell><cell>jbnu</cell><cell>0.2233</cell></row><row><cell>monobert500</cell><cell cols="2">CSIROmed 0.2136</cell></row><row><cell>senttr</cell><cell>els dshs</cell><cell>0.2128</cell></row><row><cell>Run Name</cell><cell>Team</cell><cell>MRR</cell></row><row><cell>frocchio monot5 e</cell><cell>h2oloo</cell><cell>0.7262</cell></row><row><cell>DoSSIER 2</cell><cell cols="2">DOSSIER 0.6607</cell></row><row><cell>zs bert 500</cell><cell cols="2">CSIROmed 0.6117</cell></row><row><cell>ims BM25Filtered kw*</cell><cell>iiia-unipd</cell><cell>0.6085</cell></row><row><cell>jbnu2</cell><cell>jbnu</cell><cell>0.5543</cell></row><row><cell>phir1m1</cell><cell>phi lab</cell><cell>0.5516</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4" coords="12,100.06,586.48,416.11,8.74"><head>Table 4 :</head><label>4</label><figDesc>Top 6 runs (best run for each team) for all four metrics (manual runs marked with *).</figDesc><table /></figure>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct coords="6,73.99,519.41,468.25,8.74;6,83.96,531.36,371.37,8.74" xml:id="b0">
	<analytic>
		<title level="a" type="main" coord="6,439.68,519.41,102.56,8.74;6,83.96,531.36,85.87,8.74">Overview of the TREC 2019 Decision Track</title>
		<author>
			<persName coords=""><forename type="first">M</forename><surname>Abualsaud</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">M</forename><forename type="middle">D</forename><surname>Smucker</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">C</forename><surname>Lioma</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">M</forename><surname>Maistro</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">G</forename><surname>Zuccon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="6,191.26,531.36,259.44,8.74">Proceedings of the Twenty-Eighth Text Retrieval Conference</title>
		<meeting>the Twenty-Eighth Text Retrieval Conference</meeting>
		<imprint>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="6,73.99,551.29,468.24,8.74;6,83.96,563.24,283.65,8.74" xml:id="b1">
	<analytic>
		<title level="a" type="main" coord="6,322.23,551.29,220.00,8.74;6,83.96,563.24,22.86,8.74">Overview of the TREC 2021 Health Misinformation Track</title>
		<author>
			<persName coords=""><forename type="first">C</forename><forename type="middle">L A</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">M</forename><surname>Maistro</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">M</forename><forename type="middle">D</forename><surname>Smucker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="6,128.25,563.24,234.74,8.74">Proceedings of the Thirtieth Text Retrieval Conference</title>
		<meeting>the Thirtieth Text Retrieval Conference</meeting>
		<imprint>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="6,73.99,583.17,468.24,8.74;6,83.96,595.12,374.75,8.74" xml:id="b2">
	<analytic>
		<title level="a" type="main" coord="6,386.12,583.17,156.12,8.74;6,83.96,595.12,92.67,8.74">Overview of the TREC 2020 Health Misinformation Track</title>
		<author>
			<persName coords=""><forename type="first">C</forename><forename type="middle">L A</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">M</forename><forename type="middle">D</forename><surname>Smucker</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">M</forename><surname>Maistro</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">G</forename><surname>Zuccon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="6,198.07,595.12,256.02,8.74">Proceedings of the Twenty-Ninth Text Retrieval Conference</title>
		<meeting>the Twenty-Ninth Text Retrieval Conference</meeting>
		<imprint>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="6,73.99,615.05,468.25,8.74;6,83.96,627.01,118.16,8.74" xml:id="b3">
	<analytic>
		<title level="a" type="main" coord="6,262.23,615.05,144.12,8.74">TREC Genomics Track Overview</title>
		<author>
			<persName coords=""><forename type="first">W</forename><surname>Hersh</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">R</forename><forename type="middle">T</forename><surname>Bhupatiraju</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="6,428.27,615.05,113.97,8.74;6,83.96,627.01,113.55,8.74">Proceedings of the Twelfth Text REtrieval Conference</title>
		<meeting>the Twelfth Text REtrieval Conference</meeting>
		<imprint>
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="6,73.99,646.93,468.24,8.74;6,83.96,658.89,405.74,8.74" xml:id="b4">
	<analytic>
		<title level="a" type="main" coord="6,513.73,646.93,28.50,8.74;6,83.96,658.89,135.38,8.74">TREC 2004 Genomics Track Overview</title>
		<author>
			<persName coords=""><forename type="first">W</forename><surname>Hersh</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">R</forename><forename type="middle">T</forename><surname>Bhupatiraju</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">L</forename><surname>Ross</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">P</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">A</forename><forename type="middle">M</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">D</forename><forename type="middle">F</forename><surname>Kraemer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="6,241.04,658.89,244.04,8.74">Proceedings of the Thirteenth Text REtrieval Conference</title>
		<meeting>the Thirteenth Text REtrieval Conference</meeting>
		<imprint>
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="6,73.99,678.81,468.25,8.74;6,83.96,690.77,383.39,8.74" xml:id="b5">
	<analytic>
		<title level="a" type="main" coord="6,489.24,678.81,53.00,8.74;6,83.96,690.77,112.13,8.74">TREC 2005 Genomics Track Overview</title>
		<author>
			<persName coords=""><forename type="first">W</forename><surname>Hersh</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">A</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">J</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">R</forename><forename type="middle">T</forename><surname>Bhupatiraju</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">P</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">M</forename><surname>Hearst</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="6,217.79,690.77,244.94,8.74">Proceedings of the Fourteenth Text REtrieval Conference</title>
		<meeting>the Fourteenth Text REtrieval Conference</meeting>
		<imprint>
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="10,73.99,68.18,468.24,8.74;10,83.96,80.14,254.24,8.74" xml:id="b6">
	<analytic>
		<title level="a" type="main" coord="10,370.90,68.18,166.50,8.74">TREC 2006 Genomics Track Overview</title>
		<author>
			<persName coords=""><forename type="first">W</forename><surname>Hersh</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">A</forename><forename type="middle">M</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">P</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">H</forename><forename type="middle">K</forename><surname>Rekapalli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="10,96.41,80.14,237.18,8.74">Proceedings of the Fifteenth Text REtrieval Conference</title>
		<meeting>the Fifteenth Text REtrieval Conference</meeting>
		<imprint>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="10,73.99,100.06,468.24,8.74;10,83.96,112.02,455.52,8.74" xml:id="b7">
	<analytic>
		<title level="a" type="main" coord="10,173.55,100.06,368.69,8.74;10,83.96,112.02,200.96,8.74">Adding Value to the Electronic Health Record Through Secondary Use of Data for Quality Assurance, Research, and Surveillance</title>
		<author>
			<persName coords=""><forename type="first">W</forename><forename type="middle">R</forename><surname>Hersh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" coord="10,293.55,112.02,174.86,8.74">The American Journal of Managed Care</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="277" to="278" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="10,73.99,131.95,468.24,8.74;10,83.96,143.90,458.29,8.74;10,83.96,155.86,205.69,8.74" xml:id="b8">
	<analytic>
		<title level="a" type="main" coord="10,201.18,143.90,334.89,8.74">Searching for scientific evidence in a pandemic: An overview of TREC-COVID</title>
		<author>
			<persName coords=""><forename type="first">K</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">T</forename><surname>Alam</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">S</forename><surname>Bedrick</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">D</forename><surname>Demner-Fushman</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">K</forename><surname>Lo</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">I</forename><surname>Soboroff</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">E</forename><surname>Voorhees</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">L</forename><forename type="middle">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">W</forename><forename type="middle">R</forename><surname>Hersh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" coord="10,83.96,155.86,147.61,8.74">Journal of Biomedical Informatics</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page">103865</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="10,73.99,175.78,468.24,8.74;10,83.96,187.74,379.74,8.74" xml:id="b9">
	<analytic>
		<title level="a" type="main" coord="10,385.59,175.78,156.65,8.74;10,83.96,187.74,101.11,8.74">Overview of the TREC 2016 Clinical Decision Support Track</title>
		<author>
			<persName coords=""><forename type="first">K</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">D</forename><surname>Demner-Fushman</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">E</forename><surname>Voorhees</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">W</forename><surname>Hersh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="10,206.51,187.74,252.57,8.74">Proceedings of the Twenty-Fifth Text Retrieval Conference</title>
		<meeting>the Twenty-Fifth Text Retrieval Conference</meeting>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="10,73.99,207.66,468.24,8.74;10,83.96,219.62,420.44,8.74" xml:id="b10">
	<analytic>
		<title level="a" type="main" coord="10,489.71,207.66,52.53,8.74;10,83.96,219.62,159.64,8.74">Overview of the TREC 2021 Clinical Trials Track</title>
		<author>
			<persName coords=""><forename type="first">K</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">D</forename><surname>Demner-Fushman</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">E</forename><forename type="middle">M</forename><surname>Voorhees</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">S</forename><surname>Bedrick</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">W</forename><forename type="middle">R</forename><surname>Hersh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="10,265.04,219.62,234.74,8.74">Proceedings of the Thirtieth Text Retrieval Conference</title>
		<meeting>the Thirtieth Text Retrieval Conference</meeting>
		<imprint>
			<date type="published" when="2021">2021b</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="10,73.99,239.54,468.24,8.74;10,83.96,251.50,445.18,8.74" xml:id="b11">
	<analytic>
		<title level="a" type="main" coord="10,473.35,239.54,68.89,8.74;10,83.96,251.50,163.10,8.74">Overview of the TREC 2020 Precision Medicine Track</title>
		<author>
			<persName coords=""><forename type="first">K</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">D</forename><surname>Demner-Fushman</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">E</forename><forename type="middle">M</forename><surname>Voorhees</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">W</forename><forename type="middle">R</forename><surname>Hersh</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">S</forename><surname>Bedrick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="10,268.50,251.50,256.02,8.74">Proceedings of the Twenty-Ninth Text Retrieval Conference</title>
		<meeting>the Twenty-Ninth Text Retrieval Conference</meeting>
		<imprint>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="10,73.99,271.42,468.24,8.74;10,83.96,283.38,458.28,8.74;10,83.96,295.33,50.76,8.74" xml:id="b12">
	<analytic>
		<title level="a" type="main" coord="10,83.96,283.38,228.75,8.74">Overview of the TREC 2018 Precision Medicine Track</title>
		<author>
			<persName coords=""><forename type="first">K</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">D</forename><surname>Demner-Fushman</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">E</forename><forename type="middle">M</forename><surname>Voorhees</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">W</forename><forename type="middle">R</forename><surname>Hersh</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">S</forename><surname>Bedrick</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">A</forename><surname>Lazar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="10,331.56,283.38,210.67,8.74;10,83.96,295.33,46.15,8.74">Proceedings of the Twenty-Seventh Text Retrieval Conference</title>
		<meeting>the Twenty-Seventh Text Retrieval Conference</meeting>
		<imprint>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="10,73.99,315.26,468.24,8.74;10,83.96,327.21,458.29,8.74;10,83.96,339.17,50.76,8.74" xml:id="b13">
	<analytic>
		<title level="a" type="main" coord="10,83.96,327.21,231.44,8.74">Overview of the TREC 2019 Precision Medicine Track</title>
		<author>
			<persName coords=""><forename type="first">K</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">D</forename><surname>Demner-Fushman</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">E</forename><forename type="middle">M</forename><surname>Voorhees</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">W</forename><forename type="middle">R</forename><surname>Hersh</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">S</forename><surname>Bedrick</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">A</forename><surname>Lazar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="10,335.26,327.21,206.98,8.74;10,83.96,339.17,46.15,8.74">Proceedings of the Twenty-Eighth Text Retrieval Conference</title>
		<meeting>the Twenty-Eighth Text Retrieval Conference</meeting>
		<imprint>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="10,73.99,359.09,468.24,8.74;10,83.96,371.05,458.28,8.74;10,83.96,383.00,93.03,8.74" xml:id="b14">
	<analytic>
		<title level="a" type="main" coord="10,119.68,371.05,237.66,8.74">Overview of the TREC 2017 Precision Medicine Track</title>
		<author>
			<persName coords=""><forename type="first">K</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">D</forename><surname>Demner-Fushman</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">E</forename><forename type="middle">M</forename><surname>Voorhees</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">W</forename><forename type="middle">R</forename><surname>Hersh</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">S</forename><surname>Bedrick</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">A</forename><surname>Lazar</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">S</forename><surname>Pant</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="10,379.92,371.05,162.31,8.74;10,83.96,383.00,88.42,8.74">Proceedings of the Twenty-Sixth Text Retrieval Conference</title>
		<meeting>the Twenty-Sixth Text Retrieval Conference</meeting>
		<imprint>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="10,73.99,402.93,468.24,8.74;10,83.96,414.88,387.51,8.74" xml:id="b15">
	<analytic>
		<title level="a" type="main" coord="10,377.51,402.93,164.72,8.74;10,83.96,414.88,101.11,8.74">Overview of the TREC 2015 Clinical Decision Support Track</title>
		<author>
			<persName coords=""><forename type="first">K</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">M</forename><forename type="middle">S</forename><surname>Simpson</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">E</forename><surname>Voorhees</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">W</forename><surname>Hersh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="10,206.51,414.88,260.33,8.74">Proceedings of the Twenty-Fourth Text Retrieval Conference</title>
		<meeting>the Twenty-Fourth Text Retrieval Conference</meeting>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="10,73.99,434.81,468.24,8.74;10,83.96,446.76,304.52,8.74" xml:id="b16">
	<analytic>
		<title level="a" type="main" coord="10,305.79,434.81,236.45,8.74;10,83.96,446.76,22.86,8.74">Overview of the TREC 2014 Clinical Decision Support Track</title>
		<author>
			<persName coords=""><forename type="first">M</forename><forename type="middle">S</forename><surname>Simpson</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">E</forename><surname>Voorhees</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">W</forename><surname>Hersh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="10,128.25,446.76,255.61,8.74">Proceedings of the Twenty-Third Text Retrieval Conference</title>
		<meeting>the Twenty-Third Text Retrieval Conference</meeting>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="10,73.99,466.69,468.24,8.74;10,83.96,478.65,206.77,8.74" xml:id="b17">
	<analytic>
		<title level="a" type="main" coord="10,247.59,466.69,224.14,8.74">Overview of the TREC 2012 Medical Records Track</title>
		<author>
			<persName coords=""><forename type="first">E</forename><forename type="middle">M</forename><surname>Voorhees</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">W</forename><surname>Hersh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="10,492.58,466.69,49.65,8.74;10,83.96,478.65,202.16,8.74">Proceedings of the Twenty-First Text REtrieval Conference</title>
		<meeting>the Twenty-First Text REtrieval Conference</meeting>
		<imprint>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct coords="10,73.99,498.57,468.24,8.74;10,83.96,510.53,168.57,8.74" xml:id="b18">
	<analytic>
		<title level="a" type="main" coord="10,252.27,498.57,220.73,8.74">Overview of the TREC 2011 Medical Records Track</title>
		<author>
			<persName coords=""><forename type="first">E</forename><forename type="middle">M</forename><surname>Voorhees</surname></persName>
		</author>
		<author>
			<persName coords=""><forename type="first">R</forename><forename type="middle">M</forename><surname>Tong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" coord="10,492.58,498.57,49.65,8.74;10,83.96,510.53,163.96,8.74">Proceedings of the 10th Text REtrieval Conference</title>
		<meeting>the 10th Text REtrieval Conference</meeting>
		<imprint>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
